Matches in SemOpenAlex for { <https://semopenalex.org/work/W1963889504> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W1963889504 endingPage "816" @default.
- W1963889504 startingPage "811" @default.
- W1963889504 abstract "Objective: Induction chemoradiotherapy followed by surgery may improve survival rates among patients with esophageal carcinoma. We designed a novel intense induction regimen with paclitaxel and high-dose hyperfractionated radiotherapy to maximize complete response rates. Methods: Forty patients with esophageal cancer were treated in a phase I and II trial of induction chemotherapy (cisplatin, 5-fluorouracil, and paclitaxel) at three dosage levels (75, 125, and 100 mg/m2) and concurrent hyperfractionated radiotherapy (45 Gy to the mediastinum, 58.5 Gy to the tumor). The mean age was 62 years, and 32 patients(80%) had adenocarcinoma. Twenty-eight of 40 (70%) patients had locally advanced tumors (T3, or stage IIB or greater). Results: The average hospitalization for induction treatment was 17 days. Toxicity was substantial, with esophagitis necessitating nutritional support the most common complication. The maximum tolerated dose of paclitaxel was 100 mg/m2. Two patients died during induction treatment. Thirty-six patients (90%) underwent resection. The median length of stay was 10 days, and two patients died after the operation. Fourteen of 36 patients (39%) had a pathologic complete response. Patients who received all prescribed chemotherapy had a higher pathologic complete response rate (50%) than did patients who required dose reduction (17%; p = 0.076). The 2-year survival rate was 61% (95% CI 35% to 86%) with a median follow-up of 11.9 months. Conclusions: Paclitaxel at a dose of 100 mg/m2 appears to have acceptable toxicity. The high pathologic complete response rate in this regimen is encouraging, but it is associated with substantial toxicity. The toxicity of this regimen is not acceptable and will require substantial reduction in the radiation component. Survival data are too short-term to confirm enhanced survival. (J Thorac Cardiovasc Surg 1997;114:811-6)" @default.
- W1963889504 created "2016-06-24" @default.
- W1963889504 creator A5003723404 @default.
- W1963889504 creator A5007947872 @default.
- W1963889504 creator A5010337213 @default.
- W1963889504 creator A5020135910 @default.
- W1963889504 creator A5034135402 @default.
- W1963889504 creator A5060862166 @default.
- W1963889504 creator A5077060495 @default.
- W1963889504 creator A5083104090 @default.
- W1963889504 creator A5085077580 @default.
- W1963889504 date "1997-11-01" @default.
- W1963889504 modified "2023-09-25" @default.
- W1963889504 title "Induction therapy for esophageal cancer with paclitaxel and hyperfractionated radiotherapy: A phase I and II study" @default.
- W1963889504 cites W1921758104 @default.
- W1963889504 cites W1970504928 @default.
- W1963889504 cites W2050188791 @default.
- W1963889504 cites W2051894533 @default.
- W1963889504 cites W2333224485 @default.
- W1963889504 cites W2333908381 @default.
- W1963889504 cites W2461092061 @default.
- W1963889504 doi "https://doi.org/10.1016/s0022-5223(97)70085-0" @default.
- W1963889504 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9375611" @default.
- W1963889504 hasPublicationYear "1997" @default.
- W1963889504 type Work @default.
- W1963889504 sameAs 1963889504 @default.
- W1963889504 citedByCount "62" @default.
- W1963889504 countsByYear W19638895042014 @default.
- W1963889504 countsByYear W19638895042015 @default.
- W1963889504 countsByYear W19638895042016 @default.
- W1963889504 countsByYear W19638895042017 @default.
- W1963889504 countsByYear W19638895042018 @default.
- W1963889504 crossrefType "journal-article" @default.
- W1963889504 hasAuthorship W1963889504A5003723404 @default.
- W1963889504 hasAuthorship W1963889504A5007947872 @default.
- W1963889504 hasAuthorship W1963889504A5010337213 @default.
- W1963889504 hasAuthorship W1963889504A5020135910 @default.
- W1963889504 hasAuthorship W1963889504A5034135402 @default.
- W1963889504 hasAuthorship W1963889504A5060862166 @default.
- W1963889504 hasAuthorship W1963889504A5077060495 @default.
- W1963889504 hasAuthorship W1963889504A5083104090 @default.
- W1963889504 hasAuthorship W1963889504A5085077580 @default.
- W1963889504 hasBestOaLocation W19638895041 @default.
- W1963889504 hasConcept C121608353 @default.
- W1963889504 hasConcept C126322002 @default.
- W1963889504 hasConcept C141071460 @default.
- W1963889504 hasConcept C2776611710 @default.
- W1963889504 hasConcept C2776694085 @default.
- W1963889504 hasConcept C2777292972 @default.
- W1963889504 hasConcept C2778424827 @default.
- W1963889504 hasConcept C2779134260 @default.
- W1963889504 hasConcept C2779742542 @default.
- W1963889504 hasConcept C2779920096 @default.
- W1963889504 hasConcept C2781413609 @default.
- W1963889504 hasConcept C43270747 @default.
- W1963889504 hasConcept C509974204 @default.
- W1963889504 hasConcept C71924100 @default.
- W1963889504 hasConceptScore W1963889504C121608353 @default.
- W1963889504 hasConceptScore W1963889504C126322002 @default.
- W1963889504 hasConceptScore W1963889504C141071460 @default.
- W1963889504 hasConceptScore W1963889504C2776611710 @default.
- W1963889504 hasConceptScore W1963889504C2776694085 @default.
- W1963889504 hasConceptScore W1963889504C2777292972 @default.
- W1963889504 hasConceptScore W1963889504C2778424827 @default.
- W1963889504 hasConceptScore W1963889504C2779134260 @default.
- W1963889504 hasConceptScore W1963889504C2779742542 @default.
- W1963889504 hasConceptScore W1963889504C2779920096 @default.
- W1963889504 hasConceptScore W1963889504C2781413609 @default.
- W1963889504 hasConceptScore W1963889504C43270747 @default.
- W1963889504 hasConceptScore W1963889504C509974204 @default.
- W1963889504 hasConceptScore W1963889504C71924100 @default.
- W1963889504 hasIssue "5" @default.
- W1963889504 hasLocation W19638895041 @default.
- W1963889504 hasLocation W19638895042 @default.
- W1963889504 hasOpenAccess W1963889504 @default.
- W1963889504 hasPrimaryLocation W19638895041 @default.
- W1963889504 hasRelatedWork W2128354422 @default.
- W1963889504 hasRelatedWork W2356680716 @default.
- W1963889504 hasRelatedWork W2389909172 @default.
- W1963889504 hasRelatedWork W2393085443 @default.
- W1963889504 hasRelatedWork W2394264711 @default.
- W1963889504 hasRelatedWork W2405049888 @default.
- W1963889504 hasRelatedWork W2411066725 @default.
- W1963889504 hasRelatedWork W2415196927 @default.
- W1963889504 hasRelatedWork W2997709950 @default.
- W1963889504 hasRelatedWork W3031689446 @default.
- W1963889504 hasVolume "114" @default.
- W1963889504 isParatext "false" @default.
- W1963889504 isRetracted "false" @default.
- W1963889504 magId "1963889504" @default.
- W1963889504 workType "article" @default.